Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Stephen Jones

UK TAVI Clinical Trial Manager

I joined SITU as the UK TAVI Trial Manager in March 2018. UK TAVI is an NIHR HTA funded multicentre randomised controlled trial to assess the clinical effectiveness and cost-utility of TAVI compared with conventional surgical aortic valve replacement (AVR) in patients with severe symptomatic aortic stenosis at intermediate or high operative risk.

Prior to this I worked as the Clinical Trial Administrator on the AspECT Trial for the Oncology Clinical Trials Office in the University of Oxford.